Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Owen N Witte

Showing results (11-20 of 179) with videos related to

Pageof 18
Sort By:
Molecular Oncology|August 7, 2010
Primitive origins of prostate cancer: in vivo evidence for prostate-regenerating cells and prostate cancer-initiating cellsAndrew S Goldstein, Tanya Stoyanova, Owen N Witte
Cold Spring Harbor Protocols|December 4, 2015
Tissue Recombination Models for the Study of Epithelial CancerYang Zong, Andrew S Goldstein, Owen N Witte
Cold Spring Harbor Protocols|November 4, 2015
Preparation of Urogenital Sinus Mesenchymal Cells for Prostate Tissue Recombination ModelsYang Zong, Andrew S Goldstein, Owen N Witte
Cold Spring Harbor Protocols|November 4, 2015
Dissociated Prostate Regeneration under the Renal CapsuleYang Zong, Andrew S Goldstein, Owen N Witte
International Immunology|November 18, 2005
Mutational analysis of the SH2-kinase linker region of Bruton's tyrosine kinase defines alternative modes of regulation for cytoplasmic tyrosine kinase familiesShuling Guo, Matthew I Wahl, Owen N Witte
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2003
Extending the utility of gene profiling data by bridging microarray platformsGregory Z Ferl, John M Timmerman, Owen N Witte
Molecular and Cellular Biology|February 26, 2014
Clinical targeting of mutated and wild-type protein tyrosine kinases in cancerJustin M Drake, John K Lee, Owen N Witte
Blood|January 11, 2003
Cell context-specific effects of the BCR-ABL oncogene monitored in hematopoietic progenitorsStephane Wong, Jami McLaughlin, Donghui Cheng, et al.
Biochemical Pharmacology|July 19, 2002
Lysophosphatidylcholine as a ligand for immunoregulationJanusz H S Kabarowski, Yan Xu, Owen N Witte
Molecular Cancer Research : MCR|July 23, 2013
Interleukin-6 and oncostatin-M synergize with the PI3K/AKT pathway to promote aggressive prostate malignancy in mouse and human tissuesDaniel A Smith, Atsushi Kiba, Yang Zong, et al.
Pageof 18

Showing results (11-20 of 179) with videos related to

Sort By:
Pageof 18
Molecular Oncology|August 7, 2010
Primitive origins of prostate cancer: in vivo evidence for prostate-regenerating cells and prostate cancer-initiating cellsAndrew S Goldstein, Tanya Stoyanova, Owen N Witte
Cold Spring Harbor Protocols|December 4, 2015
Tissue Recombination Models for the Study of Epithelial CancerYang Zong, Andrew S Goldstein, Owen N Witte
Cold Spring Harbor Protocols|November 4, 2015
Preparation of Urogenital Sinus Mesenchymal Cells for Prostate Tissue Recombination ModelsYang Zong, Andrew S Goldstein, Owen N Witte
Cold Spring Harbor Protocols|November 4, 2015
Dissociated Prostate Regeneration under the Renal CapsuleYang Zong, Andrew S Goldstein, Owen N Witte
International Immunology|November 18, 2005
Mutational analysis of the SH2-kinase linker region of Bruton's tyrosine kinase defines alternative modes of regulation for cytoplasmic tyrosine kinase familiesShuling Guo, Matthew I Wahl, Owen N Witte
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2003
Extending the utility of gene profiling data by bridging microarray platformsGregory Z Ferl, John M Timmerman, Owen N Witte
Molecular and Cellular Biology|February 26, 2014
Clinical targeting of mutated and wild-type protein tyrosine kinases in cancerJustin M Drake, John K Lee, Owen N Witte
Blood|January 11, 2003
Cell context-specific effects of the BCR-ABL oncogene monitored in hematopoietic progenitorsStephane Wong, Jami McLaughlin, Donghui Cheng, et al.
Biochemical Pharmacology|July 19, 2002
Lysophosphatidylcholine as a ligand for immunoregulationJanusz H S Kabarowski, Yan Xu, Owen N Witte
Molecular Cancer Research : MCR|July 23, 2013
Interleukin-6 and oncostatin-M synergize with the PI3K/AKT pathway to promote aggressive prostate malignancy in mouse and human tissuesDaniel A Smith, Atsushi Kiba, Yang Zong, et al.
Pageof 18